Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the page history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 entry was added to the history, and older items such as the government funding notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a government funding status notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 reference.SummaryDifference0.6%

- Check49 days agoChange DetectedThe page now includes a glossary toggle and color-coded diffs for changes; a new Revision: v3.4.0 note is shown, and the No FEAR Act data label capitalization has been updated.SummaryDifference0.8%

- Check63 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4; this is a minor site update that does not affect the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision label, v3.3.3, was added to the page. The HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.2%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.